For the Inventor, By the Inventor

Enter assignee name

Woburn, MA, United States of America

Azurity Pharmaceuticals, Inc.

USPTO Granted Patents = 45

EPO Patents = 4

Trademarks = 37

Forward Citations = 66

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Gerold L Mosher (13 out of 64 patents)

Zeus Pendon (10 out of 11 patents)

Scott Brauer (8 out of 13 patents)

4. Peter Mione (7 out of 12 patents)

5. Anisa Gandhi (7 out of 9 patents)

6. Steven Dinh (7 out of 8 patents)

7. Hugh Greg Thomas (6 out of 10 patents)

8. Ken Fallin (5 out of 5 patents)

9. Neal Muni (5 out of 5 patents)

10. David W Miles (5 out of 26 patents)

11. Indu Muni (5 out of 19 patents)

12. Cristina LeChiara (5 out of 8 patents)

13. Jayanta Kumar Mandal (3 out of 40 patents)

14. Priya Capila (3 out of 3 patents)

15. Swati Nagar (3 out of 9 patents)

Core Competencies:

Oral Pharmaceutical Composition

Pharmaceutical Compositions

Suspensions and Diluents

Proton Pump Inhibitor Suspension

Liquid Nimodipine Compositions

Amlodipine Formulations

Zonisamide

Vancomycin Oral Liquid

Lisinopril Formulations

Stable Pharmaceutical Compositions

Bendamustine

Omeprazole Suspension

45 patents: Sort by Forward Citations

1. 12491179 - Oral pharmaceutical composition comprising zonisamide and process of preparation thereof (2025-12-09),

2. 12458593 - Suspensions and diluents for metronidazole and baclofen (2025-11-04),

3. 12440566 - Compositions and kits for omeprazole suspension (2025-10-14),

4. 12440474 - Stable pharmaceutical compositions of clonidine (2025-10-14),

5. 12433931 - Lisinopril formulations (2025-10-07),

6. 12419867 - Stable pharmaceutical compositions of bendamustine (2025-09-23),

7. 12403140 - Pharmaceutical compositions of nilotinib (2025-09-02),

8. 12383498 - Amlodipine formulations (2025-08-12),

9. 12383491 - Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate (2025-08-12),

10. 12377081 - Liquid nimodipine compositions (2025-08-05),

11. 12357627 - Pharmaceutical compositions of cabozantinib (2025-07-15),

12. 12336984 - Amlodipine formulations (2025-06-24),

13. 12329752 - Compositions and kits for omeprazole suspension (2025-06-17),

14. 12186360 - Lisinopril formulations (2025-01-07),

15. 12186308 - Non-aqueous liquid nimodipine compositions (2025-01-07),

Azurity Pharmaceuticals, Inc. is a leading pharmaceutical company focused on providing high-quality medications to patients across various therapeutic areas. With a strong commitment to improving patient lives, Azurity develops, manufactures, and commercializes a diverse portfolio of products. Their innovative solutions and expertise enable healthcare professionals to deliver better healthcare outcomes. Visit their website to learn more about Azurity's extensive product offerings and their dedication to advancing patient care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

45 Patents

#14 in Woburn, MA

#429 in Massachusetts

#7,499 in US

#14,979 in the World

Woburn, MA, United States of America

Azurity Pharmaceuticals, Inc.

Forward Citations = 66

45 inventors:

Gerold L Mosher (13 out of 64 patents)

Zeus Pendon (10 out of 11 patents)

Scott Brauer (8 out of 13 patents)

4. Peter Mione (7 out of 12 patents)

5. Anisa Gandhi (7 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…